SLNO
Soleno Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +30.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q1 2026 | 81 | -6 | 38.38M | $1.28B | +6 | −12 |
| Q4 2025 | 86 | 0 | 43.97M | $2.04B | +1 | −1 |
| Q3 2025 | 17 | -1 | 29.19M | $1.97B | — | −1 |
| Q2 2025 | 15 | -1 | 21.84M | $1.83B | +1 | −2 |
| Q1 2025 | 13 | +4 | 13.32M | $951.87M | +4 | — |
| Q4 2024 | 9 | 0 | 8.99M | $404.33M | — | — |
| Q3 2024 | 8 | 0 | 6.39M | $322.73M | +2 | −2 |
| Q2 2024 | 8 | — | 4.85M | $197.82M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 3.32M | +16.4% | $167.74M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 1.31M | +174.0% | $66.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.31M | +174.0% | $66.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 683.17K | +73.8% | $34.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 683.17K | +73.8% | $34.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 683.17K | +73.8% | $34.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 683.17K | +73.8% | $34.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 683.17K | +73.8% | $34.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 683.17K | +73.8% | $34.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasivo) | 540.30K | +10.5% | $27.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 540.30K | +10.5% | $27.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 254.89K | -44.4% | $12.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 247.84K | Nuevo | $12.51M | 0.0% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 21.74K | +167.5% | $1.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 12.28K | Nuevo | $619,916 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 12.28K | Nuevo | $619,916 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $12.51M | 0.0% |
| AQR Capital Management | $619,916 | 0.0% |
| AQR Capital Management | $619,916 | 0.0% |
Posición cerrada
| Soros Fund Management | $4.49M | era 0.1% |
| Norges Bank | $2.36M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 224 tenedores, 55.22M acciones, $1.81B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.